Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data

BMC Systems Biology

Volumn 4, Issue , 2010, Pages

  Gu, Fei ^a   Hsu, Hang Kai ^a   Hsu, Pei Yin ^a   Wu, Jiejun ^a   Ma, Yilin ^a   Parvin, Jeffrey ^a   Huang, Tim H M ^a   Jin, Victor X ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; RNA POLYMERASE II; TAMOXIFEN;

ARTICLE; BINDING SITE; BIOLOGY; BREAST TUMOR; CHROMATIN IMMUNOPRECIPITATION; DRUG RESISTANCE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC DATABASE; GENETICS; GENOMICS; HUMAN; METABOLISM; METHODOLOGY; NUCLEOTIDE SEQUENCE; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE; TUMOR GENE;

BASE SEQUENCE; BINDING SITES; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; GENES, NEOPLASM; GENOMICS; HUMANS; RNA POLYMERASE II; TAMOXIFEN; TRANSCRIPTIONAL ACTIVATION;

EID: 78650116700     PISSN: None     EISSN: 17520509     Source Type: Journal    
DOI: 10.1186/1752-0509-4-170     Document Type: Article

References (49)

1. Kim TH, Barrera LO, Zheng M, Qu CX, Singer MA, Richmond TA, Wu YN, Green RD, Ren B. A high-resolution map of active promoters in the human genome. Nature 2005, 436:876-880. 10.1038/nature03877, 1895599, 15988478.
2. Ren B, Robert F, Wyrick JJ, Aparicio O, Jennings EG, Simon I, Zeitlinger J, Schreiber J, Hannett N, Kanin E, Volkert TL, Wilson CJ, Bell SP, Young RA. Genome-wide location and function of DNA binding proteins. Science 2000, 290:2306-2309. 10.1126/science.290.5500.2306, 11125145.
3. Weinmann AS, Yan PS, Oberley MJ, Huang TH, Farnham PJ. Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis. Genes Dev 2002, 16:235-244. 10.1101/gad.943102, 155318, 11799066.
4. Wu J, Smith LT, Plass C, Huang TH. ChIP-on-chip comes of age for genome-wide functional analysis. Cancer Res 2006, 66:6899-6902. 10.1158/0008-5472.CAN-06-0276, 16849531.
5. Roh TY, Cuddapah S, Cui K, Zhao K. The genomic landscape of histone modifications in human T cells. Proc Natl Acad Sci USA 2006, 103:15782-15787. 10.1073/pnas.0607617103, 1613230, 17043231.
6. Loh Y-H, Wu Q, Chew J-J, Vega VB, Zhang W, Chen X, Bourque G, George J, Leong B, Liu J, Wong K-Y, Sung KW, Lee CWH, Zhao X-D, Chiu K-P, Lipovich L, Kuznetsov VA, Robson P, Stanton LW, Wei C-L, Ruan Y, Lim B, Ng H-H. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature Genetics 2006, 38:431-440. 10.1038/ng1760, 16518401.
7. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, Thiessen N, Griffith OL, He A, Marra M, Snyder M, Jones S. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 2007, 4:651-657. 10.1038/nmeth1068, 17558387.
8. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, Wei G, Chepelev I, Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837. 10.1016/j.cell.2007.05.009, 17512414.
9. Johnson DS, Mortazavi A, Myers RM, Wold B. Genome-wide mapping of in vivo protein-DNA interactions. Science 2007, 316:1497-1502. 10.1126/science.1141319, 17540862.
10. Mikkelsen TS, Ku M, Jaffe DB, Issac B, Lieberman E, Giannoukos G, Alvarez P, Brockman W, Kim TK, Koche RP, Lee W, Mendenhall E, O'Donovan A, Presser A, Russ C, Xie X, Meissner A, Wernig M, Jaenisch R, Nusbaum C, Lander ES, Bernstein BE. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells. Nature 2007, 448:553-560. 10.1038/nature06008, 2921165, 17603471.
11. Osborne CK, Schiff R. Estrogen-receptor biology: continuing progress and therapeutic implications. J Clin Oncol 2005, 23:1616-1622. 10.1200/JCO.2005.10.036, 15755967.
12. Klinge CM. Estrogen receptor interaction with co-activators and co-repressors. Steroids 2000, 65:227-251. 10.1016/S0039-128X(99)00107-5, 10751636.
13. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL. Estrogen Receptor Binding to DNA Is Not Required for Its Activity through the Nonclassical AP1 Pathway. J Biol Chem 2001, 276:13615-13621.
14. Speir E, Yu ZX, Takeda K, Ferrans VJ, Cannon RO. Competition for p300 regulates transcription by estrogen receptors and nuclear factor-kappaB in human coronary smooth muscle cells. Circ Res 2000, 87:1006-1011.
15. Abdelrahim A, Samudio I, Smith R, Burghardt R, Safe S. Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J Biol Chem 2002, 277:28815-28822. 10.1074/jbc.M203828200, 12052832.
16. Gaub MP, Bellard M, Scheuer I, Chambon P, Sassone-Corsi P. Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex. Cell 1990, 63:1267-1276. 10.1016/0092-8674(90)90422-B, 2124518.
17. Carroll JS, Meyer CA, Song J, Li W, Geistlinger TR, Eeckhoute J, Brodsky AS, Keeton EK, Fertuck KC, Hall GF, Wang Q, Bekiranov S, Sementchenko V, Fox EA, Silver PA, Gingeras TR, Liu XS, Brown M. Genome-wide analysis of estrogen receptor binding sites. Nature Genetics 2006, 38:1289-1297. 10.1038/ng1901, 17013392.
18. Welboren WJ, van Driel MA, Janssen-Megens EM, van Heeringen SJ, Sweep FCGJ, Span PN, Stunnenberg HG. ChIP-Seq of ERα and RNA polymerase II defines genes differentially responding to ligands. EMBO J 2009, 28:1418-1428. 10.1038/emboj.2009.88, 2688537, 19339991.
19. Fullwood MJ, Liu MH, Pan YF, Liu J, Xu H, Mohamed YB, Orlov YL, Velkov S, Ho A, Mei PH, Chew EGY, Huang PYH, Welboren WJ, Han YY, Ooi HS, Ariyaratne PN, Vega VB, Luo YQ, Tan PY, Choy PY, Wansa KDSA, Zhao B, Lim KS, Leow SC, Yow JS, Joseph R, Li HX, Desai KV, Thomsen JS, Lee YK. An oestrogen-receptor-α-bound human chromatin interactome. Nature 2009, 462:58-64. 10.1038/nature08497, 2774924, 19890323.
20. Fan M, Yan PS, Hartman-Frey C, Chen L, Paik H, Oyer SL, Salisbury JD, Cheng AS, Li L, Abbosh PH, Huang TH, Nephew KP. Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant. Cancer Res 2006, 66:11954-11966. 10.1158/0008-5472.CAN-06-1666, 17178894.
21. Cheng AS, Jin VX, Fan M, Smith LT, Liyanarachchi S, Yan PS, Leu YW, Chan MW, Plass C, Nephew KP, Davuluri RV, Huang TH. Combinatorial analysis of transcription factor partners reveals recruitment of c-MYC to estrogen receptor-alpha responsive promoters. Mol Cell 2006, 21:393-404. 10.1016/j.molcel.2005.12.016, 16455494.
22. Jin VX, Leu YW, Liyanarachchi S, Sun H, Fan M, Nephew KP, Huang TH, Davuluri RV. Identifying estrogen receptor alpha target genes using integrated computational genomics and chromatin immunoprecipitation microarray. Nucleic Acids Res 2004, 32:6627-6635. 10.1093/nar/gkh1005, 545447, 15608294.
23. Leu YW, Yan PS, Fan M, Jin VX, Liu JC, Curran EM, Welshons WV, Wei SH, Plass C, Nephew KP, Huang TH. Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer. Cancer Res 2004, 64:8184-8192. 10.1158/0008-5472.CAN-04-2045, 15548683.
24. Carroll JS, Liu XS, Brodsky AS, Li W, Meyer CA, Szary AJ, Eeckhoute J, Shao W, Hestermann EV, Geistlinger TR, Fox EA, Silver PA, Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 2005, 122:33-43. 10.1016/j.cell.2005.05.008, 16009131.
25. Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S, Carroll JS. Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen. Nature 2008, 456:663-666. 10.1038/nature07483, 2920208, 19005469.
26. Laganière J, Deblois G, Giguère V. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells. Mol Endocrinol 2005, 19:1584-1592.
27. Massarweh S, Osborne CK, Creighton CJ, Qin L, Tsimelzon A, Huang S, Weiss H, Rimawi M, Schiff R. Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function. Cancer Res 2008, 68:826-833. 10.1158/0008-5472.CAN-07-2707, 18245484.
28. Wu M, Soler DR, Abba MC, Nunez MI, Baer R, Hatzis C, Llombart-Cussac A, Llombart-Bosch A, Aldaz CM. CtIP silencing as a novel mechanism of tamoxifen resistance in breast cancer. Mol Cancer Res 2007, 5:1285-1295. 10.1158/1541-7786.MCR-07-0126, 18171986.
29. Davuluri RV, Suzuki Y, Sugano S, Plass C, Huang TH-M. The functional consequences of alternative promoter use in mammalian genomes. Trends in Genetics 2008, 24:168-177.
30. Carroll JS, Brown M. Estrogen Receptor Target Gene: An Evolving Concept. Molecular Endocrinology 2006, 20:1707-1714. 10.1210/me.2005-0334, 16396959.
31. Komashko VM, Acevedo LG, Squazzo SL, Iyengar S, Rabinovich A, O'Geen H, Farnham PJ. Using ChIP-chip technology to reveal common principles of transcriptional repression in normal and cancer cells. Genome Res 2008, 18:521-532. 10.1101/gr.074609.107, 2279240, 18347325.
32. Kinnis M, Chen BS, Diehl AG, Isaacs GD, Zhang T, Siepel AC, Clark AG, Kraus WL. Genomic analysis of transcription factor binding, histone acetylation, and gene expression reveal mechanistically distinct classes of estrogen-regulated promoters. Molecular and Cellular Biology 2007, 27:5090-5104. 10.1128/MCB.00083-07, 1951957, 17515612.
33. Lin CY, Vega VB, Thomsen JS, Zhang T, Kong SL, Xie M, Chiu KP, Lipovich L, Barnett DH, Stossi F, Yeo A, George J, Kuznetsov VA, Lee YK, Charn TH, Palanisamy N, Miller LD, Cheung E, Katzenellenbogen BS, Ruan Y, Bourque G, Wei CL, Liu ET. Whole-genome cartography of estrogen receptor alpha binding sites. PLoS Genet 2007, 3:e87. 10.1371/journal.pgen.0030087, 1885282, 17542648.
34. Jin VX, O'Geen H, Iyengar S, Green R, Farnham PJ. Identification of an OCT4 and SRY regulatory module using integrated computational and experimental genomics approaches. Genome Res 2007, 17:807-817. 10.1101/gr.6006107, 1891340, 17567999.
35. Jin VX, Apostolos J, Nagisetty NSVR, Farnham PJ. W-ChIPMotifs: a web application tool for de novo motif discovery from ChIP-based high-throughput data. Bioinformatics 2009, 25:3191-3193. 10.1093/bioinformatics/btp570, 2778340, 19797408.
36. Wingender E, Chen X, Hehl R, Karas H, Liebich I, Matys V, Meinhardt T, Prüß M, Reuter I, Schacherer F. TRANSFAC®: an integrated system for gene expression regulation. Nucleic Acids Res 2000, 28:316-319. 10.1093/nar/28.1.316, 102445, 10592259.
37. Wasserman WW, Sandelin A. Applied bioinformatics for the identification of regulatory elements. Nat Rev Genet 2004, 5:276-287. 10.1038/nrg1315, 15131651.
38. Levy N, Zhao X, Tang H, Jaffe RB, Speed TP, Leitman DC. Multiple transcription factor elements collaborate with estrogen receptor alpha to activate an inducible estrogen response element in the NKG2E gene. Endocrinology 2007, 148:3449-3458. 10.1210/en.2006-1632, 17395694.
39. Jakacka M, Ito M, Weiss J, Chien PY, Gehm BD, Jameson JL. Estrogen Receptor Binding to DNA Is Not Required for Its Activity through the Nonclassical AP1 Pathway. J Biol Chem 2001, 276:13615-13621.
40. Carroll JS, Brown M. Estrogen receptor target gene: an evolving concept. Mol Endocrinol 2006, 20:1707-1714. 10.1210/me.2005-0334, 16396959.
41. Laganière J, Deblois G, Lefebvre C, Bataille AR, Robert F, Giguère V. Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response. Proc Natl Acad Sci USA 2005, 102:11651-11656. 1183449, 16087863.
42. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 2003, 13:2498-504. 10.1101/gr.1239303, 403769, 14597658.
43. Ernst J, Vainas O, Harbison CT, Simon I, Bar-Joseph Z. Reconstructing Dynamic Regulatory Maps. Molecular Systems Biology 2007, 3:74. 10.1038/msb4100115, 1800355, 17224918.
44. Lemmens K, Dhollander T, Bie TD, Monsieurs P, Engelen K, Smets B, Winderickx J, Moor BD, Marchal K. Inferring transcriptional module networks from ChIP-chip-, motif- and microarray data. Genome Biology 2006, 7:R37. 10.1186/gb-2006-7-5-r37, 1779513, 16677396.
45. Ross-Innes CS, Stark R, Holmes KA, Schmidt D, Spyrou C, Russell R, Massie CE, Vowler SL, Eldridge M, Carroll JS. Cooperative interaction between retinoic acid receptor-alpha and estrogen receptor in breast cancer. Genes Dev 2010, 24:171-182. 10.1101/gad.552910, 2807352, 20080953.
46. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID Bioinformatics Resources. Nature Protoc 2009, 4:44-57.
47. Robertson G, Hirst M, Bainbridge M, Bilenky M, Zhao Y, Zeng T, Euskirchen G, Bernier B, Varhol R, Delaney A, Thiessen N, Griffith OL, He A, Marra M, Snyder M, Jones S. Genome-wide profiles of STAT1 DNA association using chromatin immunoprecipitation and massively parallel sequencing. Nat Methods 2007, 4:651-657. 10.1038/nmeth1068, 17558387.
48. Frietze S, Lan X, Jin VX, Farnham PJ. Genomic targets of the KRAB and SCAN domain-containing zinc finger protein 263. J Biol Chem 2010, 285:1393-1403. 10.1074/jbc.M109.063032, 19887448.
49. Fisher RA. On the interpretation of χ2 from contingency tables, and the calculation of P. Journal of the Royal Statistical Society 1922, 85:87-94.